Medrx Co., Ltd Reports Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Provides Earnings Guidance for the Six Months Ending June 2015 and Year Ending December 31, 2015
For the six months ending June 2015, the company expects consolidated net sales of JPY 14 million, operating loss of JPY 508 million, ordinary loss of JPY 515 million, and net income of JPY 400 million or JPY 59.87 per share.
For the year ending December 31, 2015, the company expects consolidated net sales of JPY 32 million, operating loss of JPY 1,026 million, ordinary loss of JPY 1,000 million, and net income of JPY 887 million or JPY 132.67 per share.